Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Conference, Event

Five Korean SMEs Supported to Accelerate Middle East Market Entry


MegazoneCloud and the Korea Software Industry Association (KOSA) announced that they have reaped notable results from their project that provides support for large & small businesses to jointly enter the new market. Together with the Korea Foundation for Cooperation of Large & Small Business, Rural Affairs (KOFCA) under the Ministry of SMEs and Startups, they identified five promising Korean SMEs from AI and cloud sectors, which then were invited to the "Global Cloud-Based Software Company Support Project for Middle East Market Entry."

This project, hosted by MegazoneCloud and executed by KOSA, helps Korean software companies to expand their global footprint. It specifically supports activities designed to secure global references for Korean software companies, including technological advances, overseas demonstration (PoC/Pilot), and the establishment of local subsidiaries, by leveraging the host company's global cooperation framework, local network, and cloud infrastructure.

The 5 participating companies in 2024

No.

Company

Key Sector

1

DareeSoft

Riaas: real-time road risk information service

2

Dtonic

Artificial intelligence data platform

3

i-ESG

Integrated digital management solution for enterprises specializing in ESG

4

ONDA

Digital transformation solution and platform for the hospitality industry

5

FutureMain

AI-powered solution for automatic defect diagnosis and predictive maintenance to optimize equipment management

Through the 2024 project, the five enterprises benefited from comprehensive support, including cloud technology consulting, local market demonstrations, subsidiary incorporation, public relations and marketing activities, participation in the Middle East Digital Innovation Day, and access to local networks. These initiatives significantly enhanced the global recognition of the companies and their solutions, while also facilitating the localization necessary for successful market entry.

Notably, the Digital Innovation Day, held in the UAE, provided participating companies with the opportunity to expand their local network by engaging in investor relations (IR) pitching sessions with key local organizations. Additionally, legal consulting services were offered to assist in the establishment of local subsidiaries, further expand the participants' presence in the market.

An official from a participating company said, "The Digital Innovation Day event held in the UAE gave us firsthand insight into the significant demand for Korean software solutions in the Middle East," adding, "It also provided an opportunity to identify numerous references and investor requirements, which were invaluable in shaping our market entry strategy."


These press releases may also interest you

at 18:12
Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous (SC) and intravenous (IV) induction options, for the treatment of...

at 18:05
Decidr AI Industries Ltd ("the Company"), is pleased to announce that Decidr.ai Pty Ltd ("Decidr") has engaged in a multi-part strategic partnership with Amazon Web Services ("AWS") to accelerate AI-powered business transformation and the adoption...

at 18:00
Nektar Therapeutics today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference:...

at 17:59
https://perca.net/ As industries and municipalities seek sustainable solutions for wastewater treatment, a remarkable and reliable natural ally is emerging?earthworms. The study of worms for vermifiltration, a process that leverages their biological...

at 17:56
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat...

at 17:55
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced the U.S. Food and Drug Administration (FDA) approval of the supplemental New Drug Application (sNDA) for its RNAi therapeutic, AMVUTTRA® (vutrisiran), for the...



News published on and distributed by: